Skip to content

Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome

Real-world Experience With the Castor Single Branch Stent Graft in the Management of Acute Aortic Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05965453
Acronym
ECAAS
Enrollment
205
Registered
2023-07-28
Start date
2018-06-01
Completion date
2032-06-01
Last updated
2023-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Aortic Syndrome

Brief summary

The objective of this study to evaluate the safety and effectiveness of the Castor single branch stent graft for endovascular repair of acute aortic syndrome patients without an inadequate proximal landing zone (\<15mm)

Detailed description

The goal of this observational, ambispective, and multicenter cohort study is to evaluate efficacy and safety of the Castor single branch stent graft. 205 patients who received thoracic endovascular aortic repair by meant of the Castor single branch stent graft from June 2018 to June 2022 were enrolled in our study. All enrolled patients have an inadequate proximal landing zone (\<15mm) , and they underwent routine follow-up after thoracic endovascular aortic repair at 1-month, 6-months, and 1-year for the following, but not limited to assessment: physical examination, laboratory test and the CT angiography. Meanwhile, the enrolled patients will come for continuous follow-up at 2-years, 3-years, and annually to 10-years post-procedure.

Interventions

DEVICEthe Castor single branch stent graft

Participants who received thoracic endovascular aortic repair by meant of the Castor single branch stent graft from June 2018 to June 2022 were enrolled in our study.

Sponsors

Hanzhong Central Hospital
CollaboratorOTHER
Affiliated Hospital of Gansu Medical College
CollaboratorUNKNOWN
The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
CollaboratorUNKNOWN
Xianyang Hospital of Yan'an University
CollaboratorUNKNOWN
Baoji Central Hospital
CollaboratorOTHER
General Hospital of Ningxia Medical University
CollaboratorOTHER
People's Hospital of Ningxia Hui Autonomous Region
CollaboratorOTHER
Qinghai Red Cross Hospital
CollaboratorOTHER
Hanzhong People's Hospital
CollaboratorUNKNOWN
First Affiliated Hospital Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Patients with acute Stanford type B aortic syndrome who received thoracic endovascular aortic repair by meant of Castor single branch stent graft from June 2018 to June 2022

Exclusion criteria

* Patients with acute type B aortic syndrome with an adequate proximal landing zone (≥15mm) * Previous endovascular repair of the aorta * Patients with missing data and loss of follow-up

Design outcomes

Primary

MeasureTime frameDescription
Immediate post-operative technique successimmediately post operationImmediate technical success is defined as successful delivery of the aortic and branching stent graft conveyors to their predetermined position, accurate positioning and successful deployment of the stent, safe removal of the delivery device outside the body, absence of Type I and III endoleaks on angiography at the end of the procedure, and patent branch stents.
All-cause mortality and major1-year post operationAll-cause mortality includes aortic mortality, non-aortic mortality, and mortality from unknown causes.

Secondary

MeasureTime frameDescription
Major device/procedure-related adverse events of post-operation as assessed by computer tomography angiography1-month, 6-months, 1-year, and annually to 10-years post operationMajor device or procedure related major adverse events as assessed by computer tomography angiography included: death, dissection or aneurysm rupture, new myocardial infarction requiring intervention (percutaneous transluminal coronary angioplasty, bypass), retrograde type A aortic dissection, endoleaks, new disabling stroke, paraplegia, new hepatic infarction, new chronic renal insufficiency/renal failure requiring dialysis, lower limb ischemia (increase in Rutherford classification), access vessel thrombosis or rupture, conversion to open surgery, and stent migration, fracture or migration, stent graft infection, stent graft-induced new entry tear.
Aortic remodeling results as assessed by computer tomography angiography (the size of the true and false lumen of aorta, and the thrombosis degree of the false lumen of aorta)1-month, 6-months, 1-year, and annually to 10-years post operationCompare the results of computer tomography angiography before operation and on the first-, 6th- and 12th-month post operation, the expansion of the true lumen and the thrombosis of the false lumen at the coverage of the stent graft to determine whether the blood vessel is successfully remodeled
Re-intervention during follow-up1-month, 6-months, 1-year, and annually to 10-years post operationRe-intervention result from device/procedure-related adverse events.

Countries

China

Contacts

Primary ContactHongyan Tian, MD
tianhongyan2020@163.com0086-13891981101
Backup ContactMengyang Kang, MD
kmy9610@stu.xjtu.edu.cn0086-18717366324

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026